Terbinafine study for kids with scalp ringworm
Treatments studied
Part of Infections, Skin clinical trials.
This study looks at how the antifungal drug terbinafine works in children aged 2 to 18 who have tinea capitis (scalp ringworm). It aims to find the right dose to treat the infection effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is between 2 and 18 years old
- Your child has been diagnosed with tinea capitis (scalp ringworm) confirmed by a doctor using tests like a special lamp or lab cultures
- Your child has not used terbinafine on their scalp recently
- Your child does not have liver, kidney, or blood problems, and does not have conditions that affect stomach absorption
- Your child is not taking any other treatments for infections or using strong medications that affect the immune system
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares taking itraconazole continuously versus in pulses (with breaks) to treat tinea capitis (a fungal scalp infection) in children. It aims to find which method works better and is safer.
This trial tests an experimental tablet for teenagers with severe alopecia areata, a condition causing patchy hair loss. The treatment may help regrow hair with clearer information about safety and effectiveness.
This trial tests if terbinafine, an antifungal medicine, works for treating fungal infections of the ear (called otomycosis). The study will give the medicine to adults who have been diagnosed with a fungal ear infection to see if it helps clear up symptoms like itching, discharge, or debris in the ear canal.
This study tests a topical antifungal cream (terbinafine) for mild to moderate toenail fungus. It is designed for people who have a fungal infection in one or more toenails but are otherwise healthy.
This trial tests if adding a second medication, isotretinoin, to the standard itraconazole treatment works faster or better for adults with ringworm on their body. It aims to find a safer and more effective way to treat this common fungal skin infection.
This study tests a new type of injection treatment for stubborn ringworm (tinea) infections that haven't improved with standard pills or creams. It aims to see if this immunotherapy works better for hard-to-treat cases, especially when the fungus might be resistant to usual medicines.
Hear when a new Tinea Capitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.